|
Real-time Estimate
Cboe BZX
20:38:22 21/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 7.850 USD | +5.51% |
|
+3.66% | +0.84% |
| 09-18 | Verastem's Shares Not Fully Valuing its Growth Potential, RBC Says | MT |
| 09-17 | Wolfe Research Initiates Verastem at Outperform | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 674M | - | - | - | ||
| 70.88B | |||||
| 62.49B | |||||
| 26.34B | |||||
| 26.21B | - | ||||
| 24.13B | - |
- Stock Market
- Stocks
- VSTM Stock
- Charts Verastem, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
